Pulse Biosciences Inc Zukünftige P/E
Was ist das Zukünftige P/E von Pulse Biosciences Inc?
Zukünftige P/E von Pulse Biosciences Inc ist -25.38
Was ist die Definition von Zukünftige P/E?
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens für die nächsten zwölf Monate.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Zukünftige P/E von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Pulse Biosciences Inc
Was macht Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Unternehmen mit zukünftige p/e ähnlich Pulse Biosciences Inc
- Silex Systems hat Zukünftige P/E von -26.00
- White Gold hat Zukünftige P/E von -26.00
- NexGen hat Zukünftige P/E von -25.80
- Moderna Inc hat Zukünftige P/E von -25.68
- BELLUS Health hat Zukünftige P/E von -25.66
- Enviri Corp hat Zukünftige P/E von -25.49
- Pulse Biosciences Inc hat Zukünftige P/E von -25.38
- Silence Therapeutics Plc hat Zukünftige P/E von -25.28
- Calyxt Inc hat Zukünftige P/E von -25.20
- nLIGHT Inc hat Zukünftige P/E von -24.15
- Soleno Therapeutics Inc hat Zukünftige P/E von -23.96
- Performant Corp hat Zukünftige P/E von -23.95
- Rhythm Pharmaceuticals hat Zukünftige P/E von -23.85